Expertise in
8
conditions

Dr. Massoud A. Leesar

Interventional Cardiology
2000 6th Ave S, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
2000 6th Ave S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Massoud Leesar is an Interventional Cardiologist in Birmingham, Alabama. Dr. Leesar is highly rated in 8 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Heart Attack, Percutaneous Coronary Intervention (PCI), and Stent Placement.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Licenses
Internal Medicine in AL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL

Locations

2000 6th Ave S, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Enrollment Status: Completed
Publish Date: October 11, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Enrollment Status: Unknown
Publish Date: February 16, 2023
Intervention Type: Drug, Device
Study Phase: Phase 3
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Enrollment Status: Completed
Publish Date: May 14, 2021
Intervention Type: Device
Study Phase: Phase 3
The Effects of Crushed Ticagrelor Versus Eptifibatide Bolus +Clopidogrel in Troponin-Negative ACS Patients Undergoing Coronary Intervention
The Effects of Crushed Ticagrelor Versus Eptifibatide Bolus +Clopidogrel in Troponin-Negative ACS Patients Undergoing Coronary Intervention
Enrollment Status: Completed
Publish Date: May 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access: Comparisons of Oblique vs. Antero-Posterior Projections for Femoral Artery Access
Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access: Comparisons of Oblique vs. Antero-Posterior Projections for Femoral Artery Access
Enrollment Status: Completed
Publish Date: November 26, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 6 Less Clinical Trials

81 Total Publications

A Case of Thyrotoxicosis-Induced Prinzmetal Angina Mimicking Acute ST-Elevation Myocardial Infarction.
A Case of Thyrotoxicosis-Induced Prinzmetal Angina Mimicking Acute ST-Elevation Myocardial Infarction.
Journal: The American journal of medicine
Published: March 06, 2025
Similar Doctors
Expertise in
5
conditions
Dr. Gary S. Roubin
Interventional Cardiology
Expertise in
5
conditions
Dr. Gary S. Roubin
Interventional Cardiology
3980 Colonnade Pkwy, 
Birmingham, AL 
 (6.4 miles away)
205-510-5000
Languages Spoken:
English
See accepted insurances

Gary Roubin is an Interventional Cardiologist in Birmingham, Alabama. Dr. Roubin is highly rated in 5 conditions, according to our data. His top areas of expertise are Carotid Artery Disease, Atherosclerosis, Arterial Embolism, Stent Placement, and Carotid Artery Surgery.

Expertise in
63
conditions
Dr. Monica G. Hunter
Interventional Cardiology | Cardiology
Expertise in
63
conditions
Dr. Monica G. Hunter
Interventional Cardiology | Cardiology

Southview Medical Group, PC

833 St Vincents Dr, Suite 300, 
Birmingham, AL 
 (0.7 miles away)
205-933-4675
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Monica Hunter is an Interventional Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Hunter is highly rated in 63 conditions, according to our data. Her top areas of expertise are Angina, Atrial Fibrillation, Apoplexy, Atherectomy, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Hunter is currently accepting new patients.

Expertise in
60
conditions
Dr. George P. Hemstreet
Interventional Cardiology | Cardiology
Expertise in
60
conditions
Dr. George P. Hemstreet
Interventional Cardiology | Cardiology

The Dch Health Care Authority

809 University Blvd E, 
Tuscaloosa, AL 
 (46.8 miles away)
205-759-7333
Languages Spoken:
English
See accepted insurances
Accepting New Patients

George Hemstreet is an Interventional Cardiologist and a Cardiologist in Tuscaloosa, Alabama. Dr. Hemstreet is highly rated in 60 conditions, according to our data. His top areas of expertise are Angina, Mitral Valve Regurgitation, Coronary Heart Disease, Pacemaker Implantation, and Heart Bypass Surgery. Dr. Hemstreet is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leesar's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile